Global Recombinant Protein Drug R&D Market 2022 by Company, Regions, Type and Application, Forecast to 2028
The Recombinant Protein Drug R&D market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimization, trade regulations, recent developments, opportunities analysis, strategic market growth analysis, product launches, area marketplace expanding, and technological innovations.
According to our (Global Info Research) latest study, due to COVID-19 pandemic, the global Recombinant Protein Drug R&D market size is estimated to be worth US$ million in 2021 and is forecast to a readjusted size of USD million by 2028 with a CAGR of % during review period. Diabetes accounting for % of the Recombinant Protein Drug R&D global market in 2021, is projected to value USD million by 2028, growing at a % CAGR in next six years. While Peptide Hormones segment is altered to a % CAGR between 2022 and 2028.
Global key companies of Recombinant Protein Drug R&D include Eli Lilly, Novo Nordisk, Amgen, Merck, and Sanofi, etc. In terms of revenue, the global top four players hold a share over % in 2021.
Market segmentation
Recombinant Protein Drug R&D market is split by Type and by Application. For the period 2017-2028, the growth among segments provide accurate calculations and forecasts for revenue by Type and by Application. This analysis can help you expand your business by targeting qualified niche markets.
Market segment by Type, covers
Chapter 1, to describe Recombinant Protein Drug R&D product scope, market overview, market opportunities, market driving force and market risks.
Chapter 2, to profile the top players of Recombinant Protein Drug R&D, with revenue, gross margin and global market share of Recombinant Protein Drug R&D from 2019 to 2022.
Chapter 3, the Recombinant Protein Drug R&D competitive situation, revenue and global market share of top players are analyzed emphatically by landscape contrast.
Chapter 4 and 5, to segment the market size by Type and application, with revenue and growth rate by Type, application, from 2017 to 2028.
Chapter 6, 7, 8, 9, and 10, to break the market size data at the country level, with revenue and market share for key countries in the world, from 2017 to 2022.and Recombinant Protein Drug R&D market forecast, by regions, type and application, with revenue, from 2023 to 2028.
Chapter 11 and 12, to describe Recombinant Protein Drug R&D research findings and conclusion, appendix and data source.
According to our (Global Info Research) latest study, due to COVID-19 pandemic, the global Recombinant Protein Drug R&D market size is estimated to be worth US$ million in 2021 and is forecast to a readjusted size of USD million by 2028 with a CAGR of % during review period. Diabetes accounting for % of the Recombinant Protein Drug R&D global market in 2021, is projected to value USD million by 2028, growing at a % CAGR in next six years. While Peptide Hormones segment is altered to a % CAGR between 2022 and 2028.
Global key companies of Recombinant Protein Drug R&D include Eli Lilly, Novo Nordisk, Amgen, Merck, and Sanofi, etc. In terms of revenue, the global top four players hold a share over % in 2021.
Market segmentation
Recombinant Protein Drug R&D market is split by Type and by Application. For the period 2017-2028, the growth among segments provide accurate calculations and forecasts for revenue by Type and by Application. This analysis can help you expand your business by targeting qualified niche markets.
Market segment by Type, covers
- Peptide Hormones
- Hematopoietic Factor
- Cytokines
- Plasma Protein Factor
- Recombinase
- Fusion Protein
- Other
- Diabetes
- Dwarfism
- Hemophilia
- Heart Disease
- Cancer
- Other
- Eli Lilly
- Novo Nordisk
- Amgen
- Merck
- Sanofi
- Pfizer
- Roche
- Gensci
- Ankebio
- United Cell
- Sinobioway Hygene
- Kexing
- Dongbao
- 3sbio
- Gan&Lee
- Hengrui
- North America (United States, Canada, and Mexico)
- Europe (Germany, France, UK, Russia, Italy, and Rest of Europe)
- Asia-Pacific (China, Japan, South Korea, India, Southeast Asia, Australia, and Rest of Asia-Pacific)
- South America (Brazil, Argentina, Rest of South America)
- Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of Middle East & Africa)
Chapter 1, to describe Recombinant Protein Drug R&D product scope, market overview, market opportunities, market driving force and market risks.
Chapter 2, to profile the top players of Recombinant Protein Drug R&D, with revenue, gross margin and global market share of Recombinant Protein Drug R&D from 2019 to 2022.
Chapter 3, the Recombinant Protein Drug R&D competitive situation, revenue and global market share of top players are analyzed emphatically by landscape contrast.
Chapter 4 and 5, to segment the market size by Type and application, with revenue and growth rate by Type, application, from 2017 to 2028.
Chapter 6, 7, 8, 9, and 10, to break the market size data at the country level, with revenue and market share for key countries in the world, from 2017 to 2022.and Recombinant Protein Drug R&D market forecast, by regions, type and application, with revenue, from 2023 to 2028.
Chapter 11 and 12, to describe Recombinant Protein Drug R&D research findings and conclusion, appendix and data source.
1 MARKET OVERVIEW
1.1 Product Overview and Scope of Recombinant Protein Drug R&D
1.2 Classification of Recombinant Protein Drug R&D by Type
1.2.1 Overview: Global Recombinant Protein Drug R&D Market Size by Type: 2017 Versus 2021 Versus 2028
1.2.2 Global Recombinant Protein Drug R&D Revenue Market Share by Type in 2021
1.2.3 Peptide Hormones
1.2.4 Hematopoietic Factor
1.2.5 Cytokines
1.2.6 Plasma Protein Factor
1.2.7 Recombinase
1.2.8 Fusion Protein
1.2.9 Other
1.3 Global Recombinant Protein Drug R&D Market by Application
1.3.1 Overview: Global Recombinant Protein Drug R&D Market Size by Application: 2017 Versus 2021 Versus 2028
1.3.2 Diabetes
1.3.3 Dwarfism
1.3.4 Hemophilia
1.3.5 Heart Disease
1.3.6 Cancer
1.3.7 Other
1.4 Global Recombinant Protein Drug R&D Market Size & Forecast
1.5 Global Recombinant Protein Drug R&D Market Size and Forecast by Region
1.5.1 Global Recombinant Protein Drug R&D Market Size by Region: 2017 VS 2021 VS 2028
1.5.2 Global Recombinant Protein Drug R&D Market Size by Region, (2017-2022)
1.5.3 North America Recombinant Protein Drug R&D Market Size and Prospect (2017-2028)
1.5.4 Europe Recombinant Protein Drug R&D Market Size and Prospect (2017-2028)
1.5.5 Asia-Pacific Recombinant Protein Drug R&D Market Size and Prospect (2017-2028)
1.5.6 South America Recombinant Protein Drug R&D Market Size and Prospect (2017-2028)
1.5.7 Middle East and Africa Recombinant Protein Drug R&D Market Size and Prospect (2017-2028)
1.6 Market Drivers, Restraints and Trends
1.6.1 Recombinant Protein Drug R&D Market Drivers
1.6.2 Recombinant Protein Drug R&D Market Restraints
1.6.3 Recombinant Protein Drug R&D Trends Analysis
2 COMPANY PROFILES
2.1 Eli Lilly
2.1.1 Eli Lilly Details
2.1.2 Eli Lilly Major Business
2.1.3 Eli Lilly Recombinant Protein Drug R&D Product and Solutions
2.1.4 Eli Lilly Recombinant Protein Drug R&D Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.1.5 Eli Lilly Recent Developments and Future Plans
2.2 Novo Nordisk
2.2.1 Novo Nordisk Details
2.2.2 Novo Nordisk Major Business
2.2.3 Novo Nordisk Recombinant Protein Drug R&D Product and Solutions
2.2.4 Novo Nordisk Recombinant Protein Drug R&D Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.2.5 Novo Nordisk Recent Developments and Future Plans
2.3 Amgen
2.3.1 Amgen Details
2.3.2 Amgen Major Business
2.3.3 Amgen Recombinant Protein Drug R&D Product and Solutions
2.3.4 Amgen Recombinant Protein Drug R&D Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.3.5 Amgen Recent Developments and Future Plans
2.4 Merck
2.4.1 Merck Details
2.4.2 Merck Major Business
2.4.3 Merck Recombinant Protein Drug R&D Product and Solutions
2.4.4 Merck Recombinant Protein Drug R&D Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.4.5 Merck Recent Developments and Future Plans
2.5 Sanofi
2.5.1 Sanofi Details
2.5.2 Sanofi Major Business
2.5.3 Sanofi Recombinant Protein Drug R&D Product and Solutions
2.5.4 Sanofi Recombinant Protein Drug R&D Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.5.5 Sanofi Recent Developments and Future Plans
2.6 Pfizer
2.6.1 Pfizer Details
2.6.2 Pfizer Major Business
2.6.3 Pfizer Recombinant Protein Drug R&D Product and Solutions
2.6.4 Pfizer Recombinant Protein Drug R&D Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.6.5 Pfizer Recent Developments and Future Plans
2.7 Roche
2.7.1 Roche Details
2.7.2 Roche Major Business
2.7.3 Roche Recombinant Protein Drug R&D Product and Solutions
2.7.4 Roche Recombinant Protein Drug R&D Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.7.5 Roche Recent Developments and Future Plans
2.8 Gensci
2.8.1 Gensci Details
2.8.2 Gensci Major Business
2.8.3 Gensci Recombinant Protein Drug R&D Product and Solutions
2.8.4 Gensci Recombinant Protein Drug R&D Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.8.5 Gensci Recent Developments and Future Plans
2.9 Ankebio
2.9.1 Ankebio Details
2.9.2 Ankebio Major Business
2.9.3 Ankebio Recombinant Protein Drug R&D Product and Solutions
2.9.4 Ankebio Recombinant Protein Drug R&D Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.9.5 Ankebio Recent Developments and Future Plans
2.10 United Cell
2.10.1 United Cell Details
2.10.2 United Cell Major Business
2.10.3 United Cell Recombinant Protein Drug R&D Product and Solutions
2.10.4 United Cell Recombinant Protein Drug R&D Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.10.5 United Cell Recent Developments and Future Plans
2.11 Sinobioway Hygene
2.11.1 Sinobioway Hygene Details
2.11.2 Sinobioway Hygene Major Business
2.11.3 Sinobioway Hygene Recombinant Protein Drug R&D Product and Solutions
2.11.4 Sinobioway Hygene Recombinant Protein Drug R&D Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.11.5 Sinobioway Hygene Recent Developments and Future Plans
2.12 Kexing
2.12.1 Kexing Details
2.12.2 Kexing Major Business
2.12.3 Kexing Recombinant Protein Drug R&D Product and Solutions
2.12.4 Kexing Recombinant Protein Drug R&D Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.12.5 Kexing Recent Developments and Future Plans
2.13 Dongbao
2.13.1 Dongbao Details
2.13.2 Dongbao Major Business
2.13.3 Dongbao Recombinant Protein Drug R&D Product and Solutions
2.13.4 Dongbao Recombinant Protein Drug R&D Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.13.5 Dongbao Recent Developments and Future Plans
2.14 3sbio
2.14.1 3sbio Details
2.14.2 3sbio Major Business
2.14.3 3sbio Recombinant Protein Drug R&D Product and Solutions
2.14.4 3sbio Recombinant Protein Drug R&D Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.14.5 3sbio Recent Developments and Future Plans
2.15 Gan&Lee
2.15.1 Gan&Lee Details
2.15.2 Gan&Lee Major Business
2.15.3 Gan&Lee Recombinant Protein Drug R&D Product and Solutions
2.15.4 Gan&Lee Recombinant Protein Drug R&D Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.15.5 Gan&Lee Recent Developments and Future Plans
2.16 Hengrui
2.16.1 Hengrui Details
2.16.2 Hengrui Major Business
2.16.3 Hengrui Recombinant Protein Drug R&D Product and Solutions
2.16.4 Hengrui Recombinant Protein Drug R&D Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.16.5 Hengrui Recent Developments and Future Plans
3 MARKET COMPETITION, BY PLAYERS
3.1 Global Recombinant Protein Drug R&D Revenue and Share by Players (2019, 2020, 2021, and 2022)
3.2 Market Concentration Rate
3.2.1 Top 3 Recombinant Protein Drug R&D Players Market Share in 2021
3.2.2 Top 10 Recombinant Protein Drug R&D Players Market Share in 2021
3.2.3 Market Competition Trend
3.3 Recombinant Protein Drug R&D Players Head Office, Products and Services Provided
3.4 Recombinant Protein Drug R&D Mergers & Acquisitions
3.5 Recombinant Protein Drug R&D New Entrants and Expansion Plans
4 MARKET SIZE SEGMENT BY TYPE
4.1 Global Recombinant Protein Drug R&D Revenue and Market Share by Type (2017-2022)
4.2 Global Recombinant Protein Drug R&D Market Forecast by Type (2023-2028)
5 MARKET SIZE SEGMENT BY APPLICATION
5.1 Global Recombinant Protein Drug R&D Revenue Market Share by Application (2017-2022)
5.2 Global Recombinant Protein Drug R&D Market Forecast by Application (2023-2028)
6 NORTH AMERICA BY COUNTRY, BY TYPE, AND BY APPLICATION
6.1 North America Recombinant Protein Drug R&D Revenue by Type (2017-2028)
6.2 North America Recombinant Protein Drug R&D Revenue by Application (2017-2028)
6.3 North America Recombinant Protein Drug R&D Market Size by Country
6.3.1 North America Recombinant Protein Drug R&D Revenue by Country (2017-2028)
6.3.2 United States Recombinant Protein Drug R&D Market Size and Forecast (2017-2028)
6.3.3 Canada Recombinant Protein Drug R&D Market Size and Forecast (2017-2028)
6.3.4 Mexico Recombinant Protein Drug R&D Market Size and Forecast (2017-2028)
7 EUROPE BY COUNTRY, BY TYPE, AND BY APPLICATION
7.1 Europe Recombinant Protein Drug R&D Revenue by Type (2017-2028)
7.2 Europe Recombinant Protein Drug R&D Revenue by Application (2017-2028)
7.3 Europe Recombinant Protein Drug R&D Market Size by Country
7.3.1 Europe Recombinant Protein Drug R&D Revenue by Country (2017-2028)
7.3.2 Germany Recombinant Protein Drug R&D Market Size and Forecast (2017-2028)
7.3.3 France Recombinant Protein Drug R&D Market Size and Forecast (2017-2028)
7.3.4 United Kingdom Recombinant Protein Drug R&D Market Size and Forecast (2017-2028)
7.3.5 Russia Recombinant Protein Drug R&D Market Size and Forecast (2017-2028)
7.3.6 Italy Recombinant Protein Drug R&D Market Size and Forecast (2017-2028)
8 ASIA-PACIFIC BY REGION, BY TYPE, AND BY APPLICATION
8.1 Asia-Pacific Recombinant Protein Drug R&D Revenue by Type (2017-2028)
8.2 Asia-Pacific Recombinant Protein Drug R&D Revenue by Application (2017-2028)
8.3 Asia-Pacific Recombinant Protein Drug R&D Market Size by Region
8.3.1 Asia-Pacific Recombinant Protein Drug R&D Revenue by Region (2017-2028)
8.3.2 China Recombinant Protein Drug R&D Market Size and Forecast (2017-2028)
8.3.3 Japan Recombinant Protein Drug R&D Market Size and Forecast (2017-2028)
8.3.4 South Korea Recombinant Protein Drug R&D Market Size and Forecast (2017-2028)
8.3.5 India Recombinant Protein Drug R&D Market Size and Forecast (2017-2028)
8.3.6 Southeast Asia Recombinant Protein Drug R&D Market Size and Forecast (2017-2028)
8.3.7 Australia Recombinant Protein Drug R&D Market Size and Forecast (2017-2028)
9 SOUTH AMERICA BY COUNTRY, BY TYPE, AND BY APPLICATION
9.1 South America Recombinant Protein Drug R&D Revenue by Type (2017-2028)
9.2 South America Recombinant Protein Drug R&D Revenue by Application (2017-2028)
9.3 South America Recombinant Protein Drug R&D Market Size by Country
9.3.1 South America Recombinant Protein Drug R&D Revenue by Country (2017-2028)
9.3.2 Brazil Recombinant Protein Drug R&D Market Size and Forecast (2017-2028)
9.3.3 Argentina Recombinant Protein Drug R&D Market Size and Forecast (2017-2028)
10 MIDDLE EAST & AFRICA BY COUNTRY, BY TYPE, AND BY APPLICATION
10.1 Middle East & Africa Recombinant Protein Drug R&D Revenue by Type (2017-2028)
10.2 Middle East & Africa Recombinant Protein Drug R&D Revenue by Application (2017-2028)
10.3 Middle East & Africa Recombinant Protein Drug R&D Market Size by Country
10.3.1 Middle East & Africa Recombinant Protein Drug R&D Revenue by Country (2017-2028)
10.3.2 Turkey Recombinant Protein Drug R&D Market Size and Forecast (2017-2028)
10.3.3 Saudi Arabia Recombinant Protein Drug R&D Market Size and Forecast (2017-2028)
10.3.4 UAE Recombinant Protein Drug R&D Market Size and Forecast (2017-2028)
11 RESEARCH FINDINGS AND CONCLUSION
12 APPENDIX
12.1 Methodology
12.2 Research Process and Data Source
12.3 Disclaimer
1.1 Product Overview and Scope of Recombinant Protein Drug R&D
1.2 Classification of Recombinant Protein Drug R&D by Type
1.2.1 Overview: Global Recombinant Protein Drug R&D Market Size by Type: 2017 Versus 2021 Versus 2028
1.2.2 Global Recombinant Protein Drug R&D Revenue Market Share by Type in 2021
1.2.3 Peptide Hormones
1.2.4 Hematopoietic Factor
1.2.5 Cytokines
1.2.6 Plasma Protein Factor
1.2.7 Recombinase
1.2.8 Fusion Protein
1.2.9 Other
1.3 Global Recombinant Protein Drug R&D Market by Application
1.3.1 Overview: Global Recombinant Protein Drug R&D Market Size by Application: 2017 Versus 2021 Versus 2028
1.3.2 Diabetes
1.3.3 Dwarfism
1.3.4 Hemophilia
1.3.5 Heart Disease
1.3.6 Cancer
1.3.7 Other
1.4 Global Recombinant Protein Drug R&D Market Size & Forecast
1.5 Global Recombinant Protein Drug R&D Market Size and Forecast by Region
1.5.1 Global Recombinant Protein Drug R&D Market Size by Region: 2017 VS 2021 VS 2028
1.5.2 Global Recombinant Protein Drug R&D Market Size by Region, (2017-2022)
1.5.3 North America Recombinant Protein Drug R&D Market Size and Prospect (2017-2028)
1.5.4 Europe Recombinant Protein Drug R&D Market Size and Prospect (2017-2028)
1.5.5 Asia-Pacific Recombinant Protein Drug R&D Market Size and Prospect (2017-2028)
1.5.6 South America Recombinant Protein Drug R&D Market Size and Prospect (2017-2028)
1.5.7 Middle East and Africa Recombinant Protein Drug R&D Market Size and Prospect (2017-2028)
1.6 Market Drivers, Restraints and Trends
1.6.1 Recombinant Protein Drug R&D Market Drivers
1.6.2 Recombinant Protein Drug R&D Market Restraints
1.6.3 Recombinant Protein Drug R&D Trends Analysis
2 COMPANY PROFILES
2.1 Eli Lilly
2.1.1 Eli Lilly Details
2.1.2 Eli Lilly Major Business
2.1.3 Eli Lilly Recombinant Protein Drug R&D Product and Solutions
2.1.4 Eli Lilly Recombinant Protein Drug R&D Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.1.5 Eli Lilly Recent Developments and Future Plans
2.2 Novo Nordisk
2.2.1 Novo Nordisk Details
2.2.2 Novo Nordisk Major Business
2.2.3 Novo Nordisk Recombinant Protein Drug R&D Product and Solutions
2.2.4 Novo Nordisk Recombinant Protein Drug R&D Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.2.5 Novo Nordisk Recent Developments and Future Plans
2.3 Amgen
2.3.1 Amgen Details
2.3.2 Amgen Major Business
2.3.3 Amgen Recombinant Protein Drug R&D Product and Solutions
2.3.4 Amgen Recombinant Protein Drug R&D Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.3.5 Amgen Recent Developments and Future Plans
2.4 Merck
2.4.1 Merck Details
2.4.2 Merck Major Business
2.4.3 Merck Recombinant Protein Drug R&D Product and Solutions
2.4.4 Merck Recombinant Protein Drug R&D Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.4.5 Merck Recent Developments and Future Plans
2.5 Sanofi
2.5.1 Sanofi Details
2.5.2 Sanofi Major Business
2.5.3 Sanofi Recombinant Protein Drug R&D Product and Solutions
2.5.4 Sanofi Recombinant Protein Drug R&D Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.5.5 Sanofi Recent Developments and Future Plans
2.6 Pfizer
2.6.1 Pfizer Details
2.6.2 Pfizer Major Business
2.6.3 Pfizer Recombinant Protein Drug R&D Product and Solutions
2.6.4 Pfizer Recombinant Protein Drug R&D Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.6.5 Pfizer Recent Developments and Future Plans
2.7 Roche
2.7.1 Roche Details
2.7.2 Roche Major Business
2.7.3 Roche Recombinant Protein Drug R&D Product and Solutions
2.7.4 Roche Recombinant Protein Drug R&D Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.7.5 Roche Recent Developments and Future Plans
2.8 Gensci
2.8.1 Gensci Details
2.8.2 Gensci Major Business
2.8.3 Gensci Recombinant Protein Drug R&D Product and Solutions
2.8.4 Gensci Recombinant Protein Drug R&D Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.8.5 Gensci Recent Developments and Future Plans
2.9 Ankebio
2.9.1 Ankebio Details
2.9.2 Ankebio Major Business
2.9.3 Ankebio Recombinant Protein Drug R&D Product and Solutions
2.9.4 Ankebio Recombinant Protein Drug R&D Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.9.5 Ankebio Recent Developments and Future Plans
2.10 United Cell
2.10.1 United Cell Details
2.10.2 United Cell Major Business
2.10.3 United Cell Recombinant Protein Drug R&D Product and Solutions
2.10.4 United Cell Recombinant Protein Drug R&D Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.10.5 United Cell Recent Developments and Future Plans
2.11 Sinobioway Hygene
2.11.1 Sinobioway Hygene Details
2.11.2 Sinobioway Hygene Major Business
2.11.3 Sinobioway Hygene Recombinant Protein Drug R&D Product and Solutions
2.11.4 Sinobioway Hygene Recombinant Protein Drug R&D Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.11.5 Sinobioway Hygene Recent Developments and Future Plans
2.12 Kexing
2.12.1 Kexing Details
2.12.2 Kexing Major Business
2.12.3 Kexing Recombinant Protein Drug R&D Product and Solutions
2.12.4 Kexing Recombinant Protein Drug R&D Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.12.5 Kexing Recent Developments and Future Plans
2.13 Dongbao
2.13.1 Dongbao Details
2.13.2 Dongbao Major Business
2.13.3 Dongbao Recombinant Protein Drug R&D Product and Solutions
2.13.4 Dongbao Recombinant Protein Drug R&D Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.13.5 Dongbao Recent Developments and Future Plans
2.14 3sbio
2.14.1 3sbio Details
2.14.2 3sbio Major Business
2.14.3 3sbio Recombinant Protein Drug R&D Product and Solutions
2.14.4 3sbio Recombinant Protein Drug R&D Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.14.5 3sbio Recent Developments and Future Plans
2.15 Gan&Lee
2.15.1 Gan&Lee Details
2.15.2 Gan&Lee Major Business
2.15.3 Gan&Lee Recombinant Protein Drug R&D Product and Solutions
2.15.4 Gan&Lee Recombinant Protein Drug R&D Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.15.5 Gan&Lee Recent Developments and Future Plans
2.16 Hengrui
2.16.1 Hengrui Details
2.16.2 Hengrui Major Business
2.16.3 Hengrui Recombinant Protein Drug R&D Product and Solutions
2.16.4 Hengrui Recombinant Protein Drug R&D Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.16.5 Hengrui Recent Developments and Future Plans
3 MARKET COMPETITION, BY PLAYERS
3.1 Global Recombinant Protein Drug R&D Revenue and Share by Players (2019, 2020, 2021, and 2022)
3.2 Market Concentration Rate
3.2.1 Top 3 Recombinant Protein Drug R&D Players Market Share in 2021
3.2.2 Top 10 Recombinant Protein Drug R&D Players Market Share in 2021
3.2.3 Market Competition Trend
3.3 Recombinant Protein Drug R&D Players Head Office, Products and Services Provided
3.4 Recombinant Protein Drug R&D Mergers & Acquisitions
3.5 Recombinant Protein Drug R&D New Entrants and Expansion Plans
4 MARKET SIZE SEGMENT BY TYPE
4.1 Global Recombinant Protein Drug R&D Revenue and Market Share by Type (2017-2022)
4.2 Global Recombinant Protein Drug R&D Market Forecast by Type (2023-2028)
5 MARKET SIZE SEGMENT BY APPLICATION
5.1 Global Recombinant Protein Drug R&D Revenue Market Share by Application (2017-2022)
5.2 Global Recombinant Protein Drug R&D Market Forecast by Application (2023-2028)
6 NORTH AMERICA BY COUNTRY, BY TYPE, AND BY APPLICATION
6.1 North America Recombinant Protein Drug R&D Revenue by Type (2017-2028)
6.2 North America Recombinant Protein Drug R&D Revenue by Application (2017-2028)
6.3 North America Recombinant Protein Drug R&D Market Size by Country
6.3.1 North America Recombinant Protein Drug R&D Revenue by Country (2017-2028)
6.3.2 United States Recombinant Protein Drug R&D Market Size and Forecast (2017-2028)
6.3.3 Canada Recombinant Protein Drug R&D Market Size and Forecast (2017-2028)
6.3.4 Mexico Recombinant Protein Drug R&D Market Size and Forecast (2017-2028)
7 EUROPE BY COUNTRY, BY TYPE, AND BY APPLICATION
7.1 Europe Recombinant Protein Drug R&D Revenue by Type (2017-2028)
7.2 Europe Recombinant Protein Drug R&D Revenue by Application (2017-2028)
7.3 Europe Recombinant Protein Drug R&D Market Size by Country
7.3.1 Europe Recombinant Protein Drug R&D Revenue by Country (2017-2028)
7.3.2 Germany Recombinant Protein Drug R&D Market Size and Forecast (2017-2028)
7.3.3 France Recombinant Protein Drug R&D Market Size and Forecast (2017-2028)
7.3.4 United Kingdom Recombinant Protein Drug R&D Market Size and Forecast (2017-2028)
7.3.5 Russia Recombinant Protein Drug R&D Market Size and Forecast (2017-2028)
7.3.6 Italy Recombinant Protein Drug R&D Market Size and Forecast (2017-2028)
8 ASIA-PACIFIC BY REGION, BY TYPE, AND BY APPLICATION
8.1 Asia-Pacific Recombinant Protein Drug R&D Revenue by Type (2017-2028)
8.2 Asia-Pacific Recombinant Protein Drug R&D Revenue by Application (2017-2028)
8.3 Asia-Pacific Recombinant Protein Drug R&D Market Size by Region
8.3.1 Asia-Pacific Recombinant Protein Drug R&D Revenue by Region (2017-2028)
8.3.2 China Recombinant Protein Drug R&D Market Size and Forecast (2017-2028)
8.3.3 Japan Recombinant Protein Drug R&D Market Size and Forecast (2017-2028)
8.3.4 South Korea Recombinant Protein Drug R&D Market Size and Forecast (2017-2028)
8.3.5 India Recombinant Protein Drug R&D Market Size and Forecast (2017-2028)
8.3.6 Southeast Asia Recombinant Protein Drug R&D Market Size and Forecast (2017-2028)
8.3.7 Australia Recombinant Protein Drug R&D Market Size and Forecast (2017-2028)
9 SOUTH AMERICA BY COUNTRY, BY TYPE, AND BY APPLICATION
9.1 South America Recombinant Protein Drug R&D Revenue by Type (2017-2028)
9.2 South America Recombinant Protein Drug R&D Revenue by Application (2017-2028)
9.3 South America Recombinant Protein Drug R&D Market Size by Country
9.3.1 South America Recombinant Protein Drug R&D Revenue by Country (2017-2028)
9.3.2 Brazil Recombinant Protein Drug R&D Market Size and Forecast (2017-2028)
9.3.3 Argentina Recombinant Protein Drug R&D Market Size and Forecast (2017-2028)
10 MIDDLE EAST & AFRICA BY COUNTRY, BY TYPE, AND BY APPLICATION
10.1 Middle East & Africa Recombinant Protein Drug R&D Revenue by Type (2017-2028)
10.2 Middle East & Africa Recombinant Protein Drug R&D Revenue by Application (2017-2028)
10.3 Middle East & Africa Recombinant Protein Drug R&D Market Size by Country
10.3.1 Middle East & Africa Recombinant Protein Drug R&D Revenue by Country (2017-2028)
10.3.2 Turkey Recombinant Protein Drug R&D Market Size and Forecast (2017-2028)
10.3.3 Saudi Arabia Recombinant Protein Drug R&D Market Size and Forecast (2017-2028)
10.3.4 UAE Recombinant Protein Drug R&D Market Size and Forecast (2017-2028)
11 RESEARCH FINDINGS AND CONCLUSION
12 APPENDIX
12.1 Methodology
12.2 Research Process and Data Source
12.3 Disclaimer
LIST OF TABLES
Table 1. Global Recombinant Protein Drug R&D Revenue by Type, (USD Million), 2017 VS 2021 VS 2028
Table 2. Global Recombinant Protein Drug R&D Revenue by Application, (USD Million), 2017 VS 2021 VS 2028
Table 3. Global Market Recombinant Protein Drug R&D Revenue (Million USD) Comparison by Region (2017 VS 2021 VS 2028)
Table 4. Global Recombinant Protein Drug R&D Revenue (USD Million) by Region (2017-2022)
Table 5. Global Recombinant Protein Drug R&D Revenue Market Share by Region (2023-2028)
Table 6. Eli Lilly Corporate Information, Head Office, and Major Competitors
Table 7. Eli Lilly Major Business
Table 8. Eli Lilly Recombinant Protein Drug R&D Product and Solutions
Table 9. Eli Lilly Recombinant Protein Drug R&D Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 10. Novo Nordisk Corporate Information, Head Office, and Major Competitors
Table 11. Novo Nordisk Major Business
Table 12. Novo Nordisk Recombinant Protein Drug R&D Product and Solutions
Table 13. Novo Nordisk Recombinant Protein Drug R&D Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 14. Amgen Corporate Information, Head Office, and Major Competitors
Table 15. Amgen Major Business
Table 16. Amgen Recombinant Protein Drug R&D Product and Solutions
Table 17. Amgen Recombinant Protein Drug R&D Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 18. Merck Corporate Information, Head Office, and Major Competitors
Table 19. Merck Major Business
Table 20. Merck Recombinant Protein Drug R&D Product and Solutions
Table 21. Merck Recombinant Protein Drug R&D Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 22. Sanofi Corporate Information, Head Office, and Major Competitors
Table 23. Sanofi Major Business
Table 24. Sanofi Recombinant Protein Drug R&D Product and Solutions
Table 25. Sanofi Recombinant Protein Drug R&D Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 26. Pfizer Corporate Information, Head Office, and Major Competitors
Table 27. Pfizer Major Business
Table 28. Pfizer Recombinant Protein Drug R&D Product and Solutions
Table 29. Pfizer Recombinant Protein Drug R&D Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 30. Roche Corporate Information, Head Office, and Major Competitors
Table 31. Roche Major Business
Table 32. Roche Recombinant Protein Drug R&D Product and Solutions
Table 33. Roche Recombinant Protein Drug R&D Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 34. Gensci Corporate Information, Head Office, and Major Competitors
Table 35. Gensci Major Business
Table 36. Gensci Recombinant Protein Drug R&D Product and Solutions
Table 37. Gensci Recombinant Protein Drug R&D Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 38. Ankebio Corporate Information, Head Office, and Major Competitors
Table 39. Ankebio Major Business
Table 40. Ankebio Recombinant Protein Drug R&D Product and Solutions
Table 41. Ankebio Recombinant Protein Drug R&D Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 42. United Cell Corporate Information, Head Office, and Major Competitors
Table 43. United Cell Major Business
Table 44. United Cell Recombinant Protein Drug R&D Product and Solutions
Table 45. United Cell Recombinant Protein Drug R&D Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 46. Sinobioway Hygene Corporate Information, Head Office, and Major Competitors
Table 47. Sinobioway Hygene Major Business
Table 48. Sinobioway Hygene Recombinant Protein Drug R&D Product and Solutions
Table 49. Sinobioway Hygene Recombinant Protein Drug R&D Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 50. Kexing Corporate Information, Head Office, and Major Competitors
Table 51. Kexing Major Business
Table 52. Kexing Recombinant Protein Drug R&D Product and Solutions
Table 53. Kexing Recombinant Protein Drug R&D Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 54. Dongbao Corporate Information, Head Office, and Major Competitors
Table 55. Dongbao Major Business
Table 56. Dongbao Recombinant Protein Drug R&D Product and Solutions
Table 57. Dongbao Recombinant Protein Drug R&D Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 58. 3sbio Corporate Information, Head Office, and Major Competitors
Table 59. 3sbio Major Business
Table 60. 3sbio Recombinant Protein Drug R&D Product and Solutions
Table 61. 3sbio Recombinant Protein Drug R&D Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 62. Gan&Lee Corporate Information, Head Office, and Major Competitors
Table 63. Gan&Lee Major Business
Table 64. Gan&Lee Recombinant Protein Drug R&D Product and Solutions
Table 65. Gan&Lee Recombinant Protein Drug R&D Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 66. Hengrui Corporate Information, Head Office, and Major Competitors
Table 67. Hengrui Major Business
Table 68. Hengrui Recombinant Protein Drug R&D Product and Solutions
Table 69. Hengrui Recombinant Protein Drug R&D Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 70. Global Recombinant Protein Drug R&D Revenue (USD Million) by Players (2019, 2020, 2021, and 2022)
Table 71. Global Recombinant Protein Drug R&D Revenue Share by Players (2019, 2020, 2021, and 2022)
Table 72. Breakdown of Recombinant Protein Drug R&D by Company Type (Tier 1, Tier 2 and Tier 3)
Table 73. Recombinant Protein Drug R&D Players Head Office, Products and Services Provided
Table 74. Recombinant Protein Drug R&D Mergers & Acquisitions in the Past Five Years
Table 75. Recombinant Protein Drug R&D New Entrants and Expansion Plans
Table 76. Global Recombinant Protein Drug R&D Revenue (USD Million) by Type (2017-2022)
Table 77. Global Recombinant Protein Drug R&D Revenue Share by Type (2017-2022)
Table 78. Global Recombinant Protein Drug R&D Revenue Forecast by Type (2023-2028)
Table 79. Global Recombinant Protein Drug R&D Revenue by Application (2017-2022)
Table 80. Global Recombinant Protein Drug R&D Revenue Forecast by Application (2023-2028)
Table 81. North America Recombinant Protein Drug R&D Revenue by Type (2017-2022) & (USD Million)
Table 82. North America Recombinant Protein Drug R&D Revenue by Type (2023-2028) & (USD Million)
Table 83. North America Recombinant Protein Drug R&D Revenue by Application (2017-2022) & (USD Million)
Table 84. North America Recombinant Protein Drug R&D Revenue by Application (2023-2028) & (USD Million)
Table 85. North America Recombinant Protein Drug R&D Revenue by Country (2017-2022) & (USD Million)
Table 86. North America Recombinant Protein Drug R&D Revenue by Country (2023-2028) & (USD Million)
Table 87. Europe Recombinant Protein Drug R&D Revenue by Type (2017-2022) & (USD Million)
Table 88. Europe Recombinant Protein Drug R&D Revenue by Type (2023-2028) & (USD Million)
Table 89. Europe Recombinant Protein Drug R&D Revenue by Application (2017-2022) & (USD Million)
Table 90. Europe Recombinant Protein Drug R&D Revenue by Application (2023-2028) & (USD Million)
Table 91. Europe Recombinant Protein Drug R&D Revenue by Country (2017-2022) & (USD Million)
Table 92. Europe Recombinant Protein Drug R&D Revenue by Country (2023-2028) & (USD Million)
Table 93. Asia-Pacific Recombinant Protein Drug R&D Revenue by Type (2017-2022) & (USD Million)
Table 94. Asia-Pacific Recombinant Protein Drug R&D Revenue by Type (2023-2028) & (USD Million)
Table 95. Asia-Pacific Recombinant Protein Drug R&D Revenue by Application (2017-2022) & (USD Million)
Table 96. Asia-Pacific Recombinant Protein Drug R&D Revenue by Application (2023-2028) & (USD Million)
Table 97. Asia-Pacific Recombinant Protein Drug R&D Revenue by Region (2017-2022) & (USD Million)
Table 98. Asia-Pacific Recombinant Protein Drug R&D Revenue by Region (2023-2028) & (USD Million)
Table 99. South America Recombinant Protein Drug R&D Revenue by Type (2017-2022) & (USD Million)
Table 100. South America Recombinant Protein Drug R&D Revenue by Type (2023-2028) & (USD Million)
Table 101. South America Recombinant Protein Drug R&D Revenue by Application (2017-2022) & (USD Million)
Table 102. South America Recombinant Protein Drug R&D Revenue by Application (2023-2028) & (USD Million)
Table 103. South America Recombinant Protein Drug R&D Revenue by Country (2017-2022) & (USD Million)
Table 104. South America Recombinant Protein Drug R&D Revenue by Country (2023-2028) & (USD Million)
Table 105. Middle East & Africa Recombinant Protein Drug R&D Revenue by Type (2017-2022) & (USD Million)
Table 106. Middle East & Africa Recombinant Protein Drug R&D Revenue by Type (2023-2028) & (USD Million)
Table 107. Middle East & Africa Recombinant Protein Drug R&D Revenue by Application (2017-2022) & (USD Million)
Table 108. Middle East & Africa Recombinant Protein Drug R&D Revenue by Application (2023-2028) & (USD Million)
Table 109. Middle East & Africa Recombinant Protein Drug R&D Revenue by Country (2017-2022) & (USD Million)
Table 110. Middle East & Africa Recombinant Protein Drug R&D Revenue by Country (2023-2028) & (USD Million)
Table 1. Global Recombinant Protein Drug R&D Revenue by Type, (USD Million), 2017 VS 2021 VS 2028
Table 2. Global Recombinant Protein Drug R&D Revenue by Application, (USD Million), 2017 VS 2021 VS 2028
Table 3. Global Market Recombinant Protein Drug R&D Revenue (Million USD) Comparison by Region (2017 VS 2021 VS 2028)
Table 4. Global Recombinant Protein Drug R&D Revenue (USD Million) by Region (2017-2022)
Table 5. Global Recombinant Protein Drug R&D Revenue Market Share by Region (2023-2028)
Table 6. Eli Lilly Corporate Information, Head Office, and Major Competitors
Table 7. Eli Lilly Major Business
Table 8. Eli Lilly Recombinant Protein Drug R&D Product and Solutions
Table 9. Eli Lilly Recombinant Protein Drug R&D Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 10. Novo Nordisk Corporate Information, Head Office, and Major Competitors
Table 11. Novo Nordisk Major Business
Table 12. Novo Nordisk Recombinant Protein Drug R&D Product and Solutions
Table 13. Novo Nordisk Recombinant Protein Drug R&D Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 14. Amgen Corporate Information, Head Office, and Major Competitors
Table 15. Amgen Major Business
Table 16. Amgen Recombinant Protein Drug R&D Product and Solutions
Table 17. Amgen Recombinant Protein Drug R&D Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 18. Merck Corporate Information, Head Office, and Major Competitors
Table 19. Merck Major Business
Table 20. Merck Recombinant Protein Drug R&D Product and Solutions
Table 21. Merck Recombinant Protein Drug R&D Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 22. Sanofi Corporate Information, Head Office, and Major Competitors
Table 23. Sanofi Major Business
Table 24. Sanofi Recombinant Protein Drug R&D Product and Solutions
Table 25. Sanofi Recombinant Protein Drug R&D Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 26. Pfizer Corporate Information, Head Office, and Major Competitors
Table 27. Pfizer Major Business
Table 28. Pfizer Recombinant Protein Drug R&D Product and Solutions
Table 29. Pfizer Recombinant Protein Drug R&D Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 30. Roche Corporate Information, Head Office, and Major Competitors
Table 31. Roche Major Business
Table 32. Roche Recombinant Protein Drug R&D Product and Solutions
Table 33. Roche Recombinant Protein Drug R&D Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 34. Gensci Corporate Information, Head Office, and Major Competitors
Table 35. Gensci Major Business
Table 36. Gensci Recombinant Protein Drug R&D Product and Solutions
Table 37. Gensci Recombinant Protein Drug R&D Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 38. Ankebio Corporate Information, Head Office, and Major Competitors
Table 39. Ankebio Major Business
Table 40. Ankebio Recombinant Protein Drug R&D Product and Solutions
Table 41. Ankebio Recombinant Protein Drug R&D Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 42. United Cell Corporate Information, Head Office, and Major Competitors
Table 43. United Cell Major Business
Table 44. United Cell Recombinant Protein Drug R&D Product and Solutions
Table 45. United Cell Recombinant Protein Drug R&D Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 46. Sinobioway Hygene Corporate Information, Head Office, and Major Competitors
Table 47. Sinobioway Hygene Major Business
Table 48. Sinobioway Hygene Recombinant Protein Drug R&D Product and Solutions
Table 49. Sinobioway Hygene Recombinant Protein Drug R&D Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 50. Kexing Corporate Information, Head Office, and Major Competitors
Table 51. Kexing Major Business
Table 52. Kexing Recombinant Protein Drug R&D Product and Solutions
Table 53. Kexing Recombinant Protein Drug R&D Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 54. Dongbao Corporate Information, Head Office, and Major Competitors
Table 55. Dongbao Major Business
Table 56. Dongbao Recombinant Protein Drug R&D Product and Solutions
Table 57. Dongbao Recombinant Protein Drug R&D Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 58. 3sbio Corporate Information, Head Office, and Major Competitors
Table 59. 3sbio Major Business
Table 60. 3sbio Recombinant Protein Drug R&D Product and Solutions
Table 61. 3sbio Recombinant Protein Drug R&D Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 62. Gan&Lee Corporate Information, Head Office, and Major Competitors
Table 63. Gan&Lee Major Business
Table 64. Gan&Lee Recombinant Protein Drug R&D Product and Solutions
Table 65. Gan&Lee Recombinant Protein Drug R&D Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 66. Hengrui Corporate Information, Head Office, and Major Competitors
Table 67. Hengrui Major Business
Table 68. Hengrui Recombinant Protein Drug R&D Product and Solutions
Table 69. Hengrui Recombinant Protein Drug R&D Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 70. Global Recombinant Protein Drug R&D Revenue (USD Million) by Players (2019, 2020, 2021, and 2022)
Table 71. Global Recombinant Protein Drug R&D Revenue Share by Players (2019, 2020, 2021, and 2022)
Table 72. Breakdown of Recombinant Protein Drug R&D by Company Type (Tier 1, Tier 2 and Tier 3)
Table 73. Recombinant Protein Drug R&D Players Head Office, Products and Services Provided
Table 74. Recombinant Protein Drug R&D Mergers & Acquisitions in the Past Five Years
Table 75. Recombinant Protein Drug R&D New Entrants and Expansion Plans
Table 76. Global Recombinant Protein Drug R&D Revenue (USD Million) by Type (2017-2022)
Table 77. Global Recombinant Protein Drug R&D Revenue Share by Type (2017-2022)
Table 78. Global Recombinant Protein Drug R&D Revenue Forecast by Type (2023-2028)
Table 79. Global Recombinant Protein Drug R&D Revenue by Application (2017-2022)
Table 80. Global Recombinant Protein Drug R&D Revenue Forecast by Application (2023-2028)
Table 81. North America Recombinant Protein Drug R&D Revenue by Type (2017-2022) & (USD Million)
Table 82. North America Recombinant Protein Drug R&D Revenue by Type (2023-2028) & (USD Million)
Table 83. North America Recombinant Protein Drug R&D Revenue by Application (2017-2022) & (USD Million)
Table 84. North America Recombinant Protein Drug R&D Revenue by Application (2023-2028) & (USD Million)
Table 85. North America Recombinant Protein Drug R&D Revenue by Country (2017-2022) & (USD Million)
Table 86. North America Recombinant Protein Drug R&D Revenue by Country (2023-2028) & (USD Million)
Table 87. Europe Recombinant Protein Drug R&D Revenue by Type (2017-2022) & (USD Million)
Table 88. Europe Recombinant Protein Drug R&D Revenue by Type (2023-2028) & (USD Million)
Table 89. Europe Recombinant Protein Drug R&D Revenue by Application (2017-2022) & (USD Million)
Table 90. Europe Recombinant Protein Drug R&D Revenue by Application (2023-2028) & (USD Million)
Table 91. Europe Recombinant Protein Drug R&D Revenue by Country (2017-2022) & (USD Million)
Table 92. Europe Recombinant Protein Drug R&D Revenue by Country (2023-2028) & (USD Million)
Table 93. Asia-Pacific Recombinant Protein Drug R&D Revenue by Type (2017-2022) & (USD Million)
Table 94. Asia-Pacific Recombinant Protein Drug R&D Revenue by Type (2023-2028) & (USD Million)
Table 95. Asia-Pacific Recombinant Protein Drug R&D Revenue by Application (2017-2022) & (USD Million)
Table 96. Asia-Pacific Recombinant Protein Drug R&D Revenue by Application (2023-2028) & (USD Million)
Table 97. Asia-Pacific Recombinant Protein Drug R&D Revenue by Region (2017-2022) & (USD Million)
Table 98. Asia-Pacific Recombinant Protein Drug R&D Revenue by Region (2023-2028) & (USD Million)
Table 99. South America Recombinant Protein Drug R&D Revenue by Type (2017-2022) & (USD Million)
Table 100. South America Recombinant Protein Drug R&D Revenue by Type (2023-2028) & (USD Million)
Table 101. South America Recombinant Protein Drug R&D Revenue by Application (2017-2022) & (USD Million)
Table 102. South America Recombinant Protein Drug R&D Revenue by Application (2023-2028) & (USD Million)
Table 103. South America Recombinant Protein Drug R&D Revenue by Country (2017-2022) & (USD Million)
Table 104. South America Recombinant Protein Drug R&D Revenue by Country (2023-2028) & (USD Million)
Table 105. Middle East & Africa Recombinant Protein Drug R&D Revenue by Type (2017-2022) & (USD Million)
Table 106. Middle East & Africa Recombinant Protein Drug R&D Revenue by Type (2023-2028) & (USD Million)
Table 107. Middle East & Africa Recombinant Protein Drug R&D Revenue by Application (2017-2022) & (USD Million)
Table 108. Middle East & Africa Recombinant Protein Drug R&D Revenue by Application (2023-2028) & (USD Million)
Table 109. Middle East & Africa Recombinant Protein Drug R&D Revenue by Country (2017-2022) & (USD Million)
Table 110. Middle East & Africa Recombinant Protein Drug R&D Revenue by Country (2023-2028) & (USD Million)
LIST OF FIGURES
Figure 1. Recombinant Protein Drug R&D Picture
Figure 2. Global Recombinant Protein Drug R&D Revenue Market Share by Type in 2021
Figure 3. Peptide Hormones
Figure 4. Hematopoietic Factor
Figure 5. Cytokines
Figure 6. Plasma Protein Factor
Figure 7. Recombinase
Figure 8. Fusion Protein
Figure 9. Other
Figure 10. Recombinant Protein Drug R&D Revenue Market Share by Application in 2021
Figure 11. Diabetes Picture
Figure 12. Dwarfism Picture
Figure 13. Hemophilia Picture
Figure 14. Heart Disease Picture
Figure 15. Cancer Picture
Figure 16. Other Picture
Figure 17. Global Recombinant Protein Drug R&D Market Size, (USD Million): 2017 VS 2021 VS 2028
Figure 18. Global Recombinant Protein Drug R&D Revenue and Forecast (2017-2028) & (USD Million)
Figure 19. Global Recombinant Protein Drug R&D Revenue Market Share by Region (2017-2028)
Figure 20. Global Recombinant Protein Drug R&D Revenue Market Share by Region in 2021
Figure 21. North America Recombinant Protein Drug R&D Revenue (USD Million) and Growth Rate (2017-2028)
Figure 22. Europe Recombinant Protein Drug R&D Revenue (USD Million) and Growth Rate (2017-2028)
Figure 23. Asia-Pacific Recombinant Protein Drug R&D Revenue (USD Million) and Growth Rate (2017-2028)
Figure 24. South America Recombinant Protein Drug R&D Revenue (USD Million) and Growth Rate (2017-2028)
Figure 25. Middle East and Africa Recombinant Protein Drug R&D Revenue (USD Million) and Growth Rate (2017-2028)
Figure 26. Recombinant Protein Drug R&D Market Drivers
Figure 27. Recombinant Protein Drug R&D Market Restraints
Figure 28. Recombinant Protein Drug R&D Market Trends
Figure 29. Eli Lilly Recent Developments and Future Plans
Figure 30. Novo Nordisk Recent Developments and Future Plans
Figure 31. Amgen Recent Developments and Future Plans
Figure 32. Merck Recent Developments and Future Plans
Figure 33. Sanofi Recent Developments and Future Plans
Figure 34. Pfizer Recent Developments and Future Plans
Figure 35. Roche Recent Developments and Future Plans
Figure 36. Gensci Recent Developments and Future Plans
Figure 37. Ankebio Recent Developments and Future Plans
Figure 38. United Cell Recent Developments and Future Plans
Figure 39. Sinobioway Hygene Recent Developments and Future Plans
Figure 40. Kexing Recent Developments and Future Plans
Figure 41. Dongbao Recent Developments and Future Plans
Figure 42. 3sbio Recent Developments and Future Plans
Figure 43. Gan&Lee Recent Developments and Future Plans
Figure 44. Hengrui Recent Developments and Future Plans
Figure 45. Global Recombinant Protein Drug R&D Revenue Share by Players in 2021
Figure 46. Recombinant Protein Drug R&D Market Share by Company Type (Tier 1, Tier 2 and Tier 3) in 2021
Figure 47. Global Top 3 Players Recombinant Protein Drug R&D Revenue Market Share in 2021
Figure 48. Global Top 10 Players Recombinant Protein Drug R&D Revenue Market Share in 2021
Figure 49. Key Players Market Share Trend (Top 3 Market Share: 2020 VS 2021 VS 2022)
Figure 50. Global Recombinant Protein Drug R&D Revenue Share by Type in 2021
Figure 51. Global Recombinant Protein Drug R&D Market Share Forecast by Type (2023-2028)
Figure 52. Global Recombinant Protein Drug R&D Revenue Share by Application in 2021
Figure 53. Global Recombinant Protein Drug R&D Market Share Forecast by Application (2023-2028)
Figure 54. North America Recombinant Protein Drug R&D Sales Market Share by Type (2017-2028)
Figure 55. North America Recombinant Protein Drug R&D Sales Market Share by Application (2017-2028)
Figure 56. North America Recombinant Protein Drug R&D Revenue Market Share by Country (2017-2028)
Figure 57. United States Recombinant Protein Drug R&D Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 58. Canada Recombinant Protein Drug R&D Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 59. Mexico Recombinant Protein Drug R&D Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 60. Europe Recombinant Protein Drug R&D Sales Market Share by Type (2017-2028)
Figure 61. Europe Recombinant Protein Drug R&D Sales Market Share by Application (2017-2028)
Figure 62. Europe Recombinant Protein Drug R&D Revenue Market Share by Country (2017-2028)
Figure 63. Germany Recombinant Protein Drug R&D Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 64. France Recombinant Protein Drug R&D Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 65. United Kingdom Recombinant Protein Drug R&D Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 66. Russia Recombinant Protein Drug R&D Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 67. Italy Recombinant Protein Drug R&D Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 68. Asia-Pacific Recombinant Protein Drug R&D Sales Market Share by Type (2017-2028)
Figure 69. Asia-Pacific Recombinant Protein Drug R&D Sales Market Share by Application (2017-2028)
Figure 70. Asia-Pacific Recombinant Protein Drug R&D Revenue Market Share by Region (2017-2028)
Figure 71. China Recombinant Protein Drug R&D Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 72. Japan Recombinant Protein Drug R&D Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 73. South Korea Recombinant Protein Drug R&D Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 74. India Recombinant Protein Drug R&D Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 75. Southeast Asia Recombinant Protein Drug R&D Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 76. Australia Recombinant Protein Drug R&D Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 77. South America Recombinant Protein Drug R&D Sales Market Share by Type (2017-2028)
Figure 78. South America Recombinant Protein Drug R&D Sales Market Share by Application (2017-2028)
Figure 79. South America Recombinant Protein Drug R&D Revenue Market Share by Country (2017-2028)
Figure 80. Brazil Recombinant Protein Drug R&D Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 81. Argentina Recombinant Protein Drug R&D Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 82. Middle East and Africa Recombinant Protein Drug R&D Sales Market Share by Type (2017-2028)
Figure 83. Middle East and Africa Recombinant Protein Drug R&D Sales Market Share by Application (2017-2028)
Figure 84. Middle East and Africa Recombinant Protein Drug R&D Revenue Market Share by Country (2017-2028)
Figure 85. Turkey Recombinant Protein Drug R&D Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 86. Saudi Arabia Recombinant Protein Drug R&D Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 87. UAE Recombinant Protein Drug R&D Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 88. Methodology
Figure 89. Research Process and Data Source
Figure 1. Recombinant Protein Drug R&D Picture
Figure 2. Global Recombinant Protein Drug R&D Revenue Market Share by Type in 2021
Figure 3. Peptide Hormones
Figure 4. Hematopoietic Factor
Figure 5. Cytokines
Figure 6. Plasma Protein Factor
Figure 7. Recombinase
Figure 8. Fusion Protein
Figure 9. Other
Figure 10. Recombinant Protein Drug R&D Revenue Market Share by Application in 2021
Figure 11. Diabetes Picture
Figure 12. Dwarfism Picture
Figure 13. Hemophilia Picture
Figure 14. Heart Disease Picture
Figure 15. Cancer Picture
Figure 16. Other Picture
Figure 17. Global Recombinant Protein Drug R&D Market Size, (USD Million): 2017 VS 2021 VS 2028
Figure 18. Global Recombinant Protein Drug R&D Revenue and Forecast (2017-2028) & (USD Million)
Figure 19. Global Recombinant Protein Drug R&D Revenue Market Share by Region (2017-2028)
Figure 20. Global Recombinant Protein Drug R&D Revenue Market Share by Region in 2021
Figure 21. North America Recombinant Protein Drug R&D Revenue (USD Million) and Growth Rate (2017-2028)
Figure 22. Europe Recombinant Protein Drug R&D Revenue (USD Million) and Growth Rate (2017-2028)
Figure 23. Asia-Pacific Recombinant Protein Drug R&D Revenue (USD Million) and Growth Rate (2017-2028)
Figure 24. South America Recombinant Protein Drug R&D Revenue (USD Million) and Growth Rate (2017-2028)
Figure 25. Middle East and Africa Recombinant Protein Drug R&D Revenue (USD Million) and Growth Rate (2017-2028)
Figure 26. Recombinant Protein Drug R&D Market Drivers
Figure 27. Recombinant Protein Drug R&D Market Restraints
Figure 28. Recombinant Protein Drug R&D Market Trends
Figure 29. Eli Lilly Recent Developments and Future Plans
Figure 30. Novo Nordisk Recent Developments and Future Plans
Figure 31. Amgen Recent Developments and Future Plans
Figure 32. Merck Recent Developments and Future Plans
Figure 33. Sanofi Recent Developments and Future Plans
Figure 34. Pfizer Recent Developments and Future Plans
Figure 35. Roche Recent Developments and Future Plans
Figure 36. Gensci Recent Developments and Future Plans
Figure 37. Ankebio Recent Developments and Future Plans
Figure 38. United Cell Recent Developments and Future Plans
Figure 39. Sinobioway Hygene Recent Developments and Future Plans
Figure 40. Kexing Recent Developments and Future Plans
Figure 41. Dongbao Recent Developments and Future Plans
Figure 42. 3sbio Recent Developments and Future Plans
Figure 43. Gan&Lee Recent Developments and Future Plans
Figure 44. Hengrui Recent Developments and Future Plans
Figure 45. Global Recombinant Protein Drug R&D Revenue Share by Players in 2021
Figure 46. Recombinant Protein Drug R&D Market Share by Company Type (Tier 1, Tier 2 and Tier 3) in 2021
Figure 47. Global Top 3 Players Recombinant Protein Drug R&D Revenue Market Share in 2021
Figure 48. Global Top 10 Players Recombinant Protein Drug R&D Revenue Market Share in 2021
Figure 49. Key Players Market Share Trend (Top 3 Market Share: 2020 VS 2021 VS 2022)
Figure 50. Global Recombinant Protein Drug R&D Revenue Share by Type in 2021
Figure 51. Global Recombinant Protein Drug R&D Market Share Forecast by Type (2023-2028)
Figure 52. Global Recombinant Protein Drug R&D Revenue Share by Application in 2021
Figure 53. Global Recombinant Protein Drug R&D Market Share Forecast by Application (2023-2028)
Figure 54. North America Recombinant Protein Drug R&D Sales Market Share by Type (2017-2028)
Figure 55. North America Recombinant Protein Drug R&D Sales Market Share by Application (2017-2028)
Figure 56. North America Recombinant Protein Drug R&D Revenue Market Share by Country (2017-2028)
Figure 57. United States Recombinant Protein Drug R&D Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 58. Canada Recombinant Protein Drug R&D Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 59. Mexico Recombinant Protein Drug R&D Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 60. Europe Recombinant Protein Drug R&D Sales Market Share by Type (2017-2028)
Figure 61. Europe Recombinant Protein Drug R&D Sales Market Share by Application (2017-2028)
Figure 62. Europe Recombinant Protein Drug R&D Revenue Market Share by Country (2017-2028)
Figure 63. Germany Recombinant Protein Drug R&D Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 64. France Recombinant Protein Drug R&D Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 65. United Kingdom Recombinant Protein Drug R&D Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 66. Russia Recombinant Protein Drug R&D Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 67. Italy Recombinant Protein Drug R&D Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 68. Asia-Pacific Recombinant Protein Drug R&D Sales Market Share by Type (2017-2028)
Figure 69. Asia-Pacific Recombinant Protein Drug R&D Sales Market Share by Application (2017-2028)
Figure 70. Asia-Pacific Recombinant Protein Drug R&D Revenue Market Share by Region (2017-2028)
Figure 71. China Recombinant Protein Drug R&D Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 72. Japan Recombinant Protein Drug R&D Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 73. South Korea Recombinant Protein Drug R&D Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 74. India Recombinant Protein Drug R&D Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 75. Southeast Asia Recombinant Protein Drug R&D Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 76. Australia Recombinant Protein Drug R&D Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 77. South America Recombinant Protein Drug R&D Sales Market Share by Type (2017-2028)
Figure 78. South America Recombinant Protein Drug R&D Sales Market Share by Application (2017-2028)
Figure 79. South America Recombinant Protein Drug R&D Revenue Market Share by Country (2017-2028)
Figure 80. Brazil Recombinant Protein Drug R&D Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 81. Argentina Recombinant Protein Drug R&D Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 82. Middle East and Africa Recombinant Protein Drug R&D Sales Market Share by Type (2017-2028)
Figure 83. Middle East and Africa Recombinant Protein Drug R&D Sales Market Share by Application (2017-2028)
Figure 84. Middle East and Africa Recombinant Protein Drug R&D Revenue Market Share by Country (2017-2028)
Figure 85. Turkey Recombinant Protein Drug R&D Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 86. Saudi Arabia Recombinant Protein Drug R&D Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 87. UAE Recombinant Protein Drug R&D Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 88. Methodology
Figure 89. Research Process and Data Source
